SCS Hf 10 Burst denied for failing step therapy by Aetna?

Aetna's specific coverage criteria for scs hf10 burst are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denied This — and the Step-Therapy Appeal Path

A step-therapy denial for high-frequency (HF10) or burst-mode spinal cord stimulation means Aetna requires documentation that you have tried and failed a defined sequence of prior treatments before it will approve SCS. This is a common, formulaic denial — but it is frequently overturned because patients with chronic intractable pain have almost always exhausted the required prior therapies, and the documentation just needs to be assembled and presented correctly.

## Why Step-Therapy Denials Are Vulnerable

Step-therapy policies must be applied reasonably. Many states have enacted step-therapy override laws requiring insurers to grant an exception when: (1) the required prior therapy was already tried and failed; (2) the prior therapy is medically contraindicated for the patient; or (3) the prior therapy is otherwise clinically inappropriate. Your appeal should address each of these grounds and attach the supporting documentation.

Additionally, if you already received a conventional SCS trial or implant and are now seeking HF10/burst reprogramming or a device upgrade, the prior-therapy history from conventional SCS itself may satisfy the step-therapy requirement — make that argument explicitly.

## Your Federal Appeal Rights

Under ACA §2719, fully-insured plan members have the right to external review after exhausting internal appeals. ERISA §503 provides full-and-fair review rights for self-funded plan participants. The external-review window is generally four months from the final internal denial notice. Expedited review (72-hour turnaround) is available when the standard timeline would jeopardize your health.

## Appeal Timeline

1. File Level 1 internal appeal with a complete prior-treatment chronology. 2. If denied, file Level 2 if offered, then proceed to external review. 3. Simultaneously, check whether your state has a step-therapy override law and assert it in your internal appeal letters.

## Documentation to Gather

• Prior-treatment history: a comprehensive, date-ordered list of every conservative treatment tried — physical therapy, medications, injections, nerve blocks, and other interventional procedures — with provider names, approximate dates, and documented outcomes or adverse effects.
• Prescriber medical-necessity letter: the treating physician should explicitly confirm which required step-therapy treatments were tried, which failed, which were contraindicated, and why SCS is the appropriate next step.
• Chart notes and records: office visit notes, procedure records, and pharmacy history that corroborate the prior-treatment timeline.
• Aetna's step-therapy criteria: obtain the specific Clinical Policy Bulletin and list each required step; then answer each with the documented evidence.

## Criteria-Mapping Structure

List each step-therapy requirement from Aetna's policy as a numbered item. Under each item, state the documented treatment, the documented outcome or reason for failure, and cite the specific record. This structure makes it impossible for the reviewer to claim a step was not addressed.